<DOC>
	<DOCNO>NCT01843829</DOCNO>
	<brief_summary>About 7500 patient diagnosed oesophageal cancer year UK le quarter resectable disease diagnosis . There general lack consistency standard care patient across UK hospital . Patients either treat ) chemotherapy follow surgical removal tumour , b ) chemoradiotherapy follow removal tumour surgery , part standard care . Recent research support latter treatment , chemoradiotherapy maybe effective shrink tumour prevent disease spread take chemotherapy alone . However , definitive way identify treatment best without clinical trial . Evidence suggest effect chemoradiotherapy currently use standard practice may improve side effect reduce use different chemoradiotherapy combination . In trial , eligible patient receive 2 cycle chemotherapy randomise receive two different chemoradiotherapy regimen ( carboplatin paclitaxel verse oxaliplatin capecitabine ) show promising result previous study . Patients tumour remove . The best chemoradiotherapy regimen take forward Phase III trial chemoradiotherapy compare chemotherapy alone . The efficacy regimens measure count number patient ) remain free cancer , ii ) local distant spread cancer , iii ) successfully recruit iv ) experience toxicity . A specific set toxicity criterion use monitor treatment induce side-effects provide justification necessary dose modification withdrawal treatment .</brief_summary>
	<brief_title>A Feasibility Study Chemo-radiotherapy Treat Operable Oesophageal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Histologically confirm operable oesophageal cancer ( adenocarcinoma ) Tumour must stag T3 , 4 N1 ( use TNM6 stag ) T3 , T4a N13 use TNM7 stag ) Maximum disease ( Tumour plus node ) length 8 cm stag EUS CT/PET WHO performance status 01 Adequate haematological , renal , respiratory , cardiac hepatic function The patient provide write informed consent . Histologically confirm operable oesophageal cancer ( squamous cell carcinoma ) Uncontrolled angina pectoris , myocardial infarction within 6 month , heart failure , clinically significant uncontrolled cardiac arrhythmia , patient clinically significant abnormal ECG . Patients previous treatment oesophageal carcinoma . Siewert type 3 oesophagogastric tumour . T4 tumours invade contiguous structure diaphragm , crura mediastinal pleura . Patients disease follow area CT scan , EUS stag investigation : 1 . Evidence metastasis liver , lung , bone distant metastasis . 2 . Abdominal para aortic lymphadenopathy &gt; 1cm diameter CT &gt; 6mm diameter EUS . 3 . Invasion tracheobronchial tree , aorta , pericardium lung . Lymphadenopathy encase coeliac axis ( describe , patient single node lie anterior origin splenic artery anterior origin coeliac axis exclude ) . Any patient single significant medical condition think likely compromise ability tolerate therapy . Specific contraindication surgery , chemotherapeutic agent ( include know allergy chemotherapy ) radiotherapy . Pregnant lactate woman fertile woman use adequate contraception trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Oesophageal cancer</keyword>
</DOC>